SCHEMBL13848495

SCHEMBL13848495

COc1cccc(C=C2C(=O)NC(=O)NC2=O)c1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 1/20 0.58
▸ MEN1 O00255 6/20 0.57
▸ KMT2A Q03164 6/20 0.57
▸ MAPT P10636 5/20 0.57
▸ TDP1 Q9NUW8 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ ALDH1A1 P00352 6/20 0.57
▸ GAA P10253 2/20 0.55
▸ NPC1 O15118 2/20 0.52
▸ MAPK1 P28482 1/20 0.51
▸ MAP2K1 Q02750 1/20 0.51
▸ METAP1 P53582 1/20 0.49
▸ GSK3A P49840 1/20 0.48
▸ NFE2L2 Q16236 2/20 0.48
▸ HTT P42858 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ HPGD P15428 2/20 0.47
▸ MAOB P27338 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10709993 0.87 MEN1 (0.72) PDE4BMEN1KMT2AMAPTTDP1
SCHEMBL14586372 0.86 NPC1 (0.68) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL13044217 0.84 MEN1 (0.77) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL11887690 0.83 ACMSD (0.51) PDE4BMEN1KMT2AMAPTTDP1
SCHEMBL3568956 0.83 NPC1 (0.61) PDE4BMEN1KMT2AMAPTTDP1
SCHEMBL13343864 0.83 NPC1 (0.61) PDE4BMEN1KMT2AMAPTTDP1
SCHEMBL13343860 0.83 NPC1 (0.61) PDE4BMEN1KMT2AMAPTTDP1
SCHEMBL5477376 0.82 NPC1 (0.80) PDE4BMEN1KMT2AMAPTTDP1
SCHEMBL5477373 0.82 NPC1 (0.80) PDE4BMEN1KMT2AMAPTTDP1
SCHEMBL20956605 0.81 PDE4B (0.60) PDE4BMEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1305026-B1 BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS NOVUSPHARMA SPA (IT) 2009-05-13 — — EP disclosed
US-20080113993-A1 BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS VIA ARIOSTO, 23 (IT) 2008-05-15 — — US disclosed
US-20080113993-A1 BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS VIA ARIOSTO, 23 (IT) 2008-05-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113993-A1 BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS HIF1A, HIF1AN, PDGFA PDE4B 715/4885MEN1 2707/4885KMT2A 418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback